Works matching IS 14783223 AND DT 2024 AND VI 44 AND IP 4

Results: 18

Prognostic stratification in early‐stage hepatocellular carcinoma: Imaging biomarkers are needed.

Published in:

Liver International, 2024, v. 44, n. 4, p. 881, doi. 10.1111/liv.15869

By:

Dana, Jérémy;
Sutter, Olivier

Publication type:

Article

Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults.

Published in:

Liver International, 2024, v. 44, n. 4, p. 1051, doi. 10.1111/liv.15856

By:

Song, Rui;
Li, Zhao;
Zhang, Yingzhi;
Tan, Jiahe;
Chen, Zhiwei

Publication type:

Article

Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa.

Published in:

Liver International, 2024, v. 44, n. 4, p. 1061, doi. 10.1111/liv.15852

By:

Younossi, Zobair M.;
Golabi, Pegah;
Paik, James;
Owrangi, Soroor;
Yilmaz, Yusuf;
El‐Kassas, Mohamed;
Alswat, Khalid;
Alqahtani, Saleh A.

Publication type:

Article

Issue Information.

Published in:: Liver International, 2024, v. 44, n. 4, p. 877, doi. 10.1111/liv.15909
Publication type:: Article

Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020.

Published in:

Liver International, 2024, v. 44, n. 4, p. 1024, doi. 10.1111/liv.15841

By:

Harney, Brendan L.;
Sacks‐Davis, Rachel;
van Santen, Daniela K.;
Traeger, Michael W.;
Wilkinson, Anna L.;
Asselin, Jason;
Fairley, Christopher K.;
Roth, Norman;
Bloch, Mark;
Matthews, Gail V.;
Donovan, Basil;
Guy, Rebecca;
Stoové, Mark;
Hellard, Margaret E.;
Doyle, Joseph S.

Publication type:

Article

Impact of ACSL4 on the prognosis of hepatocellular carcinoma: Association with cancer‐associated fibroblasts and the tumour immune microenvironment.

Published in:

Liver International, 2024, v. 44, n. 4, p. 1011, doi. 10.1111/liv.15839

By:

Toshida, Katsuya;
Itoh, Shinji;
Iseda, Norifumi;
Tomiyama, Takahiro;
Yoshiya, Shohei;
Toshima, Takeo;
Liu, Yu‐Chen;
Iwasaki, Takeshi;
Okuzaki, Daisuke;
Taniguchi, Koji;
Oda, Yoshinao;
Mori, Masaki;
Yoshizumi, Tomoharu

Publication type:

Article

Sodium–glucose linked transporter 2 inhibitors in liver cirrhosis: Beyond their antidiabetic use.

Published in:

Liver International, 2024, v. 44, n. 4, p. 884, doi. 10.1111/liv.15851

By:

Siafarikas, Christos;
Kapelios, Chris J.;
Papatheodoridi, Margarita;
Vlachogiannakos, John;
Tentolouris, Nikolaos;
Papatheodoridis, George

Publication type:

Article

Cardiac remodelling in non‐alcoholic fatty liver disease in the general population.

Published in:

Liver International, 2024, v. 44, n. 4, p. 1032, doi. 10.1111/liv.15844

By:

Kostka, Frederik;
Ittermann, Till;
Groß, Stefan;
Laqua, Fabian Christopher;
Bülow, Robin;
Völzke, Henry;
Dörr, Marcus;
Kühn, Jens Peter;
Markus, Marcello Ricardo Paulista;
Kromrey, Marie‐Luise

Publication type:

Article

Evidence for the elimination of viral hepatitis B and C in Egypt: Results of a nationwide survey in 2022.

Published in:

Liver International, 2024, v. 44, n. 4, p. 955, doi. 10.1111/liv.15843

By:

Kandeel, Amr;
Fahim, Manal;
Abukamar, Shimaa;
BahaaEldin, Hala;
Abuelsood, Hanaa;
Samy, Sahar;
Deghedy, Ola;
Sheta, Amany;
Naguib, Amel;
El Guindy, Nancy;
Youssef, Amr;
Kamel, Reham;
Afifi, Salma;
El‐Kassas, Moahmed;
Abdelghaffar, Khaled

Publication type:

Article

A Transformer‐Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablation.

Published in:

Liver International, 2024, v. 44, n. 4, p. 894, doi. 10.1111/liv.15846

By:

Wang, Wentao;
Wang, Yueyue;
Song, Danjun;
Zhou, Yingting;
Luo, Rongkui;
Ying, Siqi;
Yang, Li;
Sun, Wei;
Cai, Jiabin;
Wang, Xi;
Bao, Zhen;
Zheng, Jiaping;
Zeng, Mengsu;
Gao, Qiang;
Wang, Xiaoying;
Zhou, Jian;
Wang, Manning;
Shao, Guoliang;
Rao, Sheng‐xiang;
Zhu, Kai

Publication type:

Article

Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus.

Published in:

Liver International, 2024, v. 44, n. 4, p. 1042, doi. 10.1111/liv.15845

By:

Lavrado, Natália Coelho;
Salles, Gil Fernando;
Cardoso, Claudia Regina Lopes;
de França, Paulo Henrique Condeixa;
Melo, Maria Fernanda Di Guimarães Gonçalves;
Leite, Nathalie Carvalho;
Villela‐Nogueira, Cristiane Alves

Publication type:

Article

Cost‐effectiveness study of FIB‐4 followed by transient elastography screening strategy for advanced hepatic fibrosis in a NAFLD at‐risk population.

Published in:

Liver International, 2024, v. 44, n. 4, p. 944, doi. 10.1111/liv.15838

By:

Park, Huiyul;
Yoon, Eileen L.;
Kim, Mimi;
Kwon, Sun‐Hong;
Kim, Donghee;
Cheung, Ramsey;
Kim, Hye‐Lin;
Jun, Dae Won

Publication type:

Article

Cirrhosis‐downregulated LSECtin can be retrieved by cytokines, shifts the TLR‐induced LSECs secretome and correlates with the hepatic Th response.

Published in:

Liver International, 2024, v. 44, n. 4, p. 996, doi. 10.1111/liv.15836

By:

Martínez‐López, Sebastián;
Ángel‐Gomis, Enrique;
Gómez‐Hurtado, Isabel;
Fernández‐Iglesias, Anabel;
Morante, Javier;
Gracia‐Sancho, Jordi;
Boix, Paula;
Cubero, Francisco J.;
Zapater, Pedro;
Caparrós, Esther;
Francés, Rubén

Publication type:

Article

No correlation between MASLD and poor outcome of Atezolizumab‐Bevacizumab therapy in patients with advanced HCC.

Published in:

Liver International, 2024, v. 44, n. 4, p. 931, doi. 10.1111/liv.15833

By:

Copil, Francisca‐Dora;
Campani, Claudia;
Lequoy, Marie;
Sultanik, Philippe;
Blaise, Lorraine;
Wagner, Mathilde;
Ganne‐Carrié, Nathalie;
Ozenne, Violaine;
Thabut, Dominique;
Nault, Jean‐Charles;
Ratziu, Vlad;
Allaire, Manon

Publication type:

Article

Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study.

Published in:

Liver International, 2024, v. 44, n. 4, p. 920, doi. 10.1111/liv.15831

By:

Cai, Mingyue;
Huang, Wensou;
Liang, Wei;
Guo, Yongjian;
Liang, Licong;
Lin, Liteng;
Xie, Lulu;
Zhou, Jingwen;
Chen, Ye;
Cao, Bihui;
Wu, Jingqiang;
Zhu, Kangshun

Publication type:

Article

Bulk and single‐cell transcriptome reveal the immuno‐prognostic subtypes and tumour microenvironment heterogeneity in HCC.

Published in:

Liver International, 2024, v. 44, n. 4, p. 979, doi. 10.1111/liv.15828

By:

Ji, Daihan;
Lu, Shuting;
Zhang, Huarong;
Li, Zhenli;
Wang, Shenglin;
Miao, Tongjie;
Jiang, Zhiyu;
Ao, Lu

Publication type:

Article

Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC.

Published in:

Liver International, 2024, v. 44, n. 4, p. 907, doi. 10.1111/liv.15826

By:

Yang, Jiwon;
Choi, Jonggi;
Choi, Won‐Mook;
Kim, Kang Mo;
Lee, Han Chu;
Shim, Ju Hyun

Publication type:

Article

Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH.

Published in:

Liver International, 2024, v. 44, n. 4, p. 966, doi. 10.1111/liv.15816

By:

Alkhouri, Naim;
LaCerte, Carl;
Edwards, Jeffrey;
Poordad, Fred;
Lawitz, Eric;
Lee, Lois;
Karan, Sharon;
Sawhney, Sangeeta;
Erickson, Mary;
MacConell, Leigh;
Zaru, Luna;
Chen, Jianfen;
Campagna, Jason

Publication type:

Article